SCHEMBL6839167

SCHEMBL6839167

COc1ccc(C(=O)Cc2ccncc2)c2c1OCCO2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
HSD17B10 Q99714 1/20 0.58
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
PDE4B Q07343 1/20 0.42
PDE4A P27815 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
HTT P42858 1/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.40
KDM4C Q9H3R0 1/20 0.38
PDE4D Q08499 1/20 0.38
HIF1A Q16665 1/20 0.38
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6837535 0.99 LMNA (0.57) LMNAKDM4EALDH1A1HSD17B10CTNNB1
SCHEMBL8307586 0.95 LMNA (0.52) LMNAKDM4EALDH1A1HSD17B10CTNNB1
Hydrochloric Acid SCHEMBL6838119 0.94 LMNA (0.51) LMNAKDM4EALDH1A1HSD17B10CTNNB1
SCHEMBL5722859 0.81 PDE4A (0.45) LMNAKDM4EPDE4BPDE4ASMN1; SMN2
SCHEMBL5722791 0.80 LMNA (0.39) LMNAKDM4EALDH1A1HSD17B10PDE4B
Hydrochloric Acid SCHEMBL5723084 0.80 PDE4A (0.44) LMNAKDM4EPDE4BPDE4ASMN1; SMN2
SCHEMBL22825094 0.79 KDM4E (0.69) LMNAKDM4EALDH1A1HSD17B10CTNNB1
SCHEMBL6838082 0.79 PDE4D (0.65) LMNAKDM4EALDH1A1HSD17B10PDE4B
SCHEMBL5723155 0.78 HSP90AA1 (0.44) LMNAPDE4BPDE4ASMN1; SMN2HTT
SCHEMBL11175790 0.78 KDM4E (0.68) LMNAKDM4EALDH1A1HSD17B10CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed
EP-0943613-A1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1999-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 LMNA 1848/4885KDM4E 3975/4885ALDH1A1 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.